Drug WatchNasal Spray Formulation of the Opioid Antagonist Naloxone ApprovedAschenbrenner, Diane S. MS, RNAuthor Information Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: firstname.lastname@example.org. AJN, American Journal of Nursing: April 2016 - Volume 116 - Issue 4 - p 20,21 doi: 10.1097/01.NAJ.0000482133.81929.44 Buy Metrics Abstract A nasal spray formulation (Narcan Nasal Spray) of the opioid antagonist naloxone has been approved. This formulation is intended to be easier for friends and family members of victims to administer than injectable formulations. Friends and family must receive education regarding the administration of naloxone nasal spray and be told that emergency medical care is necessary even after the naloxone is administered. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.